- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02868645
Interest of Serum Periostin Dosage in Patients With Bone Fibrous Dysplasia (PERIOSTINE)
November 5, 2018 updated by: Hospices Civils de Lyon
Fibrous dysplasia is a rare bone disease which can cause pain and fractures.
It has been shown that periostin is over expressed in fibrous component in patients bones ; but periostin has never been measured out in serum of patients, although it is easy to assess.
This study aims to show whether serum periostin is elevated in serum of patients with fibrous dysplasia, and if it is more elevated in patients with severe forms of the disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon cedex 03, France, 69437
- Service de rhumatologie Pavillon F - Hôpital Edouard Herriot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with fibrous dysplasia of the bone
- access to social security
- informed consent
Exclusion Criteria:
- no informed consent
- pregnancy
- patients with a history of conditions known to increase periostin serum (stade IV cancer, severe asthma, pulmonary fibrosis…)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients with bone fibrous dysplasia
Patients with bone fibrous dysplasia will have a blood sampling to assess periostin rate in serum
|
Patients with bone fibrous dysplasia will have blood sampling to assess periostin rate in serum
|
No Intervention: Control subjects
Control subjects will have no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Periostin rate in serum
Time Frame: At inclusion
|
At inclusion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Periostin rate in serum according to the number of fibrotic bones
Time Frame: At inclusion
|
At inclusion
|
Periostin rate in serum in patients with severe phenotype of the disease
Time Frame: At inclusion
|
At inclusion
|
Periostin rate in serum in patients with Mac Cune Albright syndrome
Time Frame: At inclusion
|
At inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 25, 2016
Primary Completion (Actual)
April 10, 2018
Study Completion (Actual)
April 10, 2018
Study Registration Dates
First Submitted
August 11, 2016
First Submitted That Met QC Criteria
August 11, 2016
First Posted (Estimate)
August 16, 2016
Study Record Updates
Last Update Posted (Actual)
November 7, 2018
Last Update Submitted That Met QC Criteria
November 5, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL15_0336
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Fibrous Dysplasia
-
National Institute of Dental and Craniofacial Research...CompletedPolyostotic Fibrous DysplasiaUnited States
-
National Institute of Dental and Craniofacial Research...CompletedPolyostotic Fibrous DysplasiaUnited States
-
Cairo UniversityUnknownCraniofacial Fibrous DysplasiaEgypt
-
National Institute of Dental and Craniofacial Research...CompletedPolyostotic Fibrous DysplasiaUnited States
-
Boston Children's HospitalNational Institutes of Health (NIH)Enrolling by invitation
-
Chang Gung Memorial HospitalCompletedCraniofacial Fibrous DysplasiaTaiwan
-
Hospices Civils de LyonCompletedFibrous Dysplasia of Bone | McCune Albright SyndromeFrance
-
National Institute of Dental and Craniofacial Research...Active, not recruitingFibrous Dysplasia Of BoneUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPrecocious Puberty | Polyostotic Fibrous DysplasiaUnited States
-
Tovah BursteinRecruitingFibrous Dysplasia | McCune Albright Syndrome | Mazabraud SyndromeUnited States
Clinical Trials on Blood sampling
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
CardioRenalCompletedPotassium MeasurementBelgium
-
Centre Hospitalier Universitaire DijonCompletedPatients With Intellectual Disabilities Without an Obvious Clinical Diagnosis | Patients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)France
-
Assistance Publique - Hôpitaux de ParisUnknownSepsis | Acute Circulatory FailureFrance
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Rennes University HospitalCompletedMultiple SclerosisFrance
-
Institut PasteurSanofi Pasteur, a Sanofi Company; Institut Pasteur of Cote d'IvoireCompletedBordetella Pertussis, Whooping CoughCôte D'Ivoire
-
University Hospital, ToulouseCompletedPneumonia, PneumocystisFrance
-
Royal Surrey County Hospital NHS Foundation TrustCompletedThyroid Carcinoma | Thyroid Cancer | Cancer of the Thyroid | Cancer of ThyroidUnited Kingdom
-
Institut CurieRecruitingProstate Cancer | Healthy DonorsFrance